Skip to content
SamaHealth
Get in touch

Long-term conditions in West Bengal, followed as one person, not five lists

West Bengal now has more raised blood sugar and blood pressure than India as a whole, and the gap opened in the last three years. Anubhav Life Care, a neighbourhood lab in Barasat, holds four years of results for 1,15,829 people. This page sets the state against the country, then shows what those results say: how common each condition is among the people tested, how often they come together, which follow-up checks never happen, and what changes in the same person over time.

Lab figures: real, from the lab's AKTIV records, Oct 2022 to Oct 2026, 1,74,520 visits linked into 1,15,829 people, 4,35,472 numeric results, 81,776 ultrasound and 8,883 echo reports; published as counts only · West Bengal and India figures: published surveys, cited.

62%
of adults tested have at least one chronic condition
of 61,474 tested in at least one of nine areas
20.1%
of adults tested for sugar have diabetes
women 17.4%, men 24.0%; n 24,915
36.6%
of people with diabetes ever had an HbA1c
7,843 people; 7.2% ever had a urine ACR
59%
of people aged 60-74 have two or more conditions
among those tested in three or more areas

West Bengal against India

Noncommunicable diseases cause 63% of deaths in India (WHO). Every West Bengal and India figure is published and linked to its source; the last column of the condition table is the lab's own.

NFHS-6 2023-24 vs NFHS-5 2019-21adults 15+ unless stated

Same survey, same method: West Bengal and India

% of adults, NFHS-6 2023-24; the dark tick marks NFHS-5 2019-21

Women: blood sugar over 140 mg/dL or on medicine
West BengalAnubhav 17.4%22.7% +5.2 since NFHS-5Anubhav 17.4%
India17.8% +4.3 since NFHS-5
Men: blood sugar over 140 mg/dL or on medicine
West BengalAnubhav 24.0%26.8% +5.5 since NFHS-5Anubhav 24.0%
India20.9% +5.3 since NFHS-5
Women: blood sugar over 160 mg/dL
West Bengal12.1% +4.4 since NFHS-5
India9.1% +2.8 since NFHS-5
Men: blood sugar over 160 mg/dL
West Bengal14.3% +4.8 since NFHS-5
India10.9% +3.8 since NFHS-5
Women: blood pressure 140/90+ or on medicine
West Bengal24.3% +3.8 since NFHS-5
India19.4% −1.9 since NFHS-5
Men: blood pressure 140/90+ or on medicine
West Bengal24.9% +4.8 since NFHS-5
India22.1% −1.9 since NFHS-5
Women 15-49: overweight or obese (BMI 25+)
West Bengal34.6% +11.9 since NFHS-5
India30.7% +6.7 since NFHS-5
Men 15-49: overweight or obese (BMI 25+)
West Bengal24.5% +8.3 since NFHS-5
India27.3% +4.4 since NFHS-5
Men: use any tobacco
West Bengal46.2% −1.9 since NFHS-5
India36.3% −1.7 since NFHS-5
  • West Bengal
  • India
Anubhav Life Care, adults tested

West Bengal is above India on every blood sugar and blood pressure measure, for women and for men. Raised blood pressure rose in West Bengal (women 20.5% to 24.3%, men 20.1% to 24.9%) while it fell nationally. Blood sugar over 160 mg/dL, the level that usually means untreated or uncontrolled diabetes, rose by about half in five years. The sun marks Anubhav's adults with confirmed diabetes: women 17.4%, men 24.0%, a little under the state's survey figure, which also counts any single random reading over 140. The lab has no blood pressure, weight or tobacco data, so those rows have no mark. Source: NFHS-6 (2023-24) fact sheets, IIPS / MoHFW 2026.

Condition by condition

best published estimate for each; studies differ in method, age and year, so read across a row with care

ConditionWest BengalIndiaThis lab, adults tested
Diabetes22.7% / 26.8%women / men, random sugar over 140 or on medicine · NFHS-6 (2023-24) fact sheets, IIPS / MoHFW 202611.4%adults 20+, OGTT or HbA1c; NFHS-6 equivalent 17.8% / 20.9% · Anjana et al., ICMR-INDIAB-17, Lancet Diabetes Endocrinol 202320.1%women 17.4% / men 24.0% · HbA1c 6.5% or more, or a diabetic-range sugar on two days (ADA); n 24,915
High blood pressure24.3% / 24.9%women / men, 140/90+ or on medicine · NFHS-6 (2023-24) fact sheets, IIPS / MoHFW 202635.5%adults 20+; NFHS-6 equivalent 19.4% / 22.1% · Anjana et al., ICMR-INDIAB-17, Lancet Diabetes Endocrinol 2023not a lab test
Kidney disease4.1%adults over 30 with eGFR under 60, rural South 24 Parganas · Gallieni et al., Sci World J 20143.5–17.2%range across methods and settings · Singh et al., SEEK-India, BMC Nephrol 201313%eGFR under 60 at any test; n 15,136
High cholesterolno open estimatestate figures sit in the INDIAB-17 appendix; not reproduced here24.0%total cholesterol 200 mg/dL or more · Anjana et al., ICMR-INDIAB-17, Lancet Diabetes Endocrinol 202316.1%LDL 130 mg/dL or more; total cholesterol was not counted; n 8,936
Hypothyroidism21.7%Kolkata, highest of eight cities · Unnikrishnan et al., Indian J Endocrinol Metab 201310.95%eight-city average; 15.9% of women, 5.0% of men · Unnikrishnan et al. 201323.9%women 24.0% / men 23.6% · TSH over 4.5, overt or subclinical; n 14,962
Fatty liver8.7%rural adults by ultrasound, 2010; 75% of them not overweight · Das et al., Hepatology 201038.6%pooled across 50 studies, mostly urban and later · Shalimar et al., J Clin Exp Hepatol 202252.3%women 50.4% / men 55.7% · any grade on ultrasound; n 29,488
Anaemia71.4%women 15-49, NFHS-5 2019-21; the highest of any state · NFHS-5 fact sheets, IIPS 202157.0%women 15-49, NFHS-5 2019-21 · NFHS-5 fact sheets, IIPS 202161.6%women 69.9% / men 45.4% · WHO haemoglobin cut-offs, all adults; n 21,521

The lab column is not a prevalence. People come to a lab because a doctor suspected something, so it runs above a household survey wherever testing is selective: fatty liver and kidney disease most of all, because scans and creatinine are ordered for people with symptoms or diabetes. Where testing is routine the lab sits close to the survey: diabetes among women 17.4% against NFHS-6's 22.7% for West Bengal, anaemia among women 69.9% against NFHS-5's 71.4%, hypothyroidism 23.9% against Kolkata's 21.7%. All three sit above India.

What the lab found

Every condition the lab's results can define, among adults who had the test that defines it. Definitions follow ADA, KDIGO, NCEP, ATA and WHO; ultrasound and echo findings are read from the report text by rule-based extractors on the clinic PC, which send back flags, never text. The standardised column reweights each rate to the age and sex mix of all 1,02,882 adults seen, so conditions tested mostly in older people can be compared with the rest.

Oct 2022 to Oct 20261,02,882 adults63.8% womenmedian age 40
ConditionAdults testedWith the condition% (95% CI)Age-sex standardised %
Metabolic
Diabetes (confirmed)24,9154,99920.1 (19.6–20.6)16.5
Diabetes incl. unconfirmed24,9157,84331.5 (30.9–32.1)26.1
Prediabetes (latest)24,9155,99224 (23.5–24.6)21.9
Dyslipidaemia (any)8,9366,13868.7 (67.7–69.6)70.6
LDL >= 1308,9361,43916.1 (15.4–16.9)15.5
LDL >= 1908,936911 (0.8–1.2)0.9
Triglycerides >= 1508,9363,26836.6 (35.6–37.6)34.6
Low HDL8,9364,12046.1 (45.1–47.1)50.2
Atherogenic dyslipidaemia (TG high + low HDL)8,9361,98922.3 (21.4–23.1)21.8
Hyperuricaemia6,2131,74528.1 (27–29.2)25.6
Fatty liver on USG29,48815,43452.3 (51.8–52.9)51.3
MASLD (fatty liver + cardiometabolic factor)29,4882,6489 (8.7–9.3)8.9
MASLD among fatty liver with a metabolic test3,6272,64873 (71.5–74.4)67.8
Vitamin D deficiency (< 20)1,83569237.7 (35.5–40)39.8
Renal
CKD: eGFR < 60 (ever)15,1361,97513 (12.5–13.6)8.8
CKD: eGFR < 60 persistent >= 90 d15,1362621.7 (1.5–2)1.1
CKD: eGFR < 60 (latest)15,1361,86912.3 (11.8–12.9)8.4
Albuminuria (UACR >= 30)1,18058749.7 (46.9–52.6)46.7
Severe albuminuria (UACR > 300)1,18020817.6 (15.6–19.9)16.9
Dipstick proteinuria >= 1+ (any)6,21682813.3 (12.5–14.2)12.5
Any CKD marker (eGFR < 60 or UACR >= 30)15,3812,35215.3 (14.7–15.9)10.6
Renal parenchymal disease on USG56,4951,2102.1 (2–2.3)3.1
Nephrolithiasis on USG56,4953,3315.9 (5.7–6.1)6.7
Cardiac
Reduced LVEF (< 50%)7,9844125.2 (4.7–5.7)3.6
HF with reduced EF (< 40%)7,9841521.9 (1.6–2.2)1.4
LV hypertrophy7,9841,68221.1 (20.2–22)14.9
Diastolic dysfunction (any grade)7,9844,62057.9 (56.8–58.9)43.5
Diastolic dysfunction grade >= II7,9842232.8 (2.5–3.2)2
Ischaemic heart disease (RWMA / hypokinesia)7,9847159 (8.3–9.6)6.2
Moderate-severe valve disease7,9842513.1 (2.8–3.5)2.4
Pulmonary hypertension7,9842132.7 (2.3–3)2
Atrial fibrillation / flutter7,984170.2 (0.1–0.3)0.1
Structural heart disease (composite)7,98496012 (11.3–12.8)8.6
Subclinical remodelling (LVH / DD>=II / dilated LA)7,9842,03925.5 (24.6–26.5)18.2
Hepatic
Transaminitis (ALT > 40 or AST > 35)10,4123,81136.6 (35.7–37.5)35.6
ALT > 2x ULN10,4121,07110.3 (9.7–10.9)10.4
FIB-4 >= 2.67 (advanced fibrosis likely)3,78446412.3 (11.3–13.3)7.5
FIB-4 indeterminate or high3,7841,62843 (41.5–44.6)27.5
Chronic liver disease / cirrhosis on USG29,4881,3764.7 (4.4–4.9)4.6
Hepatomegaly on USG29,48810,89236.9 (36.4–37.5)36.2
Gallstones on USG56,4952,3924.2 (4.1–4.4)4.7
Thyroid
Hypothyroidism (overt, TSH > 10)14,9626524.4 (4–4.7)4.3
Subclinical hypothyroidism (TSH 4.5-10)14,9622,92319.5 (18.9–20.2)19.4
Hypothyroidism (any)14,9623,57523.9 (23.2–24.6)23.7
Hyperthyroidism (TSH < 0.45)14,9624012.7 (2.4–3)2.6
Thyroid dysfunction (any)14,9623,97626.6 (25.9–27.3)26.3
Haematologic
Anaemia (WHO)21,52113,25361.6 (60.9–62.2)59.8
Moderate-severe anaemia (Hb < 11)21,5216,59130.6 (30–31.2)29.2
Inflammatory
Raised CRP (> 6 mg/L)4,0781,66440.8 (39.3–42.3)39.7
Urological
Prostatomegaly on USG (men 40+)9,7972,60026.5 (25.7–27.4)19
PSA > 4 ng/mL (men)73813618.4 (15.8–21.4)10.2
Reproductive-metabolic
PCOS morphology on USG (women 15-45)32,8545,09115.5 (15.1–15.9)10.3
Respiratory
Obstructive ventilatory defect (PFT)54816930.8 (27.1–34.8)26.7
Restrictive ventilatory defect (PFT)54813324.3 (20.9–28)24.9

Read each row as “of the adults who had this test”. Fatty liver on 52.3% of scans is a referral rate, not a state rate; the 2010 rural West Bengal survey found 8.7%. eGFR under 60 at any test (13%) overstates kidney disease because most people had one creatinine; only 1.7% were confirmed 90 days apart. Breathing tests (548) and PSA (738) are too few to quote.

Per 1,000 adults tested, by year

same definitions each year; 2022 covers November and December only

YearAdults seenDiabetesDyslipidaemiaCKD (eGFR<60)Fatty liverHypothyroidAnaemiaStructural heart dis.
20222,180300679109550237653122
202320,507323714131536273628132
202430,051332697125571241649112
202536,375344667138519216599109
202632,126340655134531227612125

Diabetes per 1,000 adults tested rose from 323 in 2023 to 344 in 2025, in the same direction as NFHS-6. Who gets tested also changes from year to year, so treat this as agreement, not a trend estimate.

The same people, with several conditions

Visits are linked into one person by phone number, name, sex and age, so each person is counted once however often they came. Nine areas are counted: diabetes, dyslipidaemia, kidney disease, fatty liver, hypothyroidism, anaemia, raised uric acid, structural heart disease and raised liver enzymes.

20,609 adults tested in 3+ areasCKM: 52,671 adults staged

Conditions per person

adults tested in three or more of the nine areas, n = 20,609

  • None15%
  • One36.4%
  • Two28.4%
  • Three14.2%
  • Four or more6%

Nearly half the people tested broadly (48.6%) have two or more conditions. Restricting to people tested in three areas leans toward the sicker; among everyone tested in at least one area the figure is 18.6%.

Two or more conditions, by age

same people

  • 18-2926.1%
  • 30-4446%
  • 45-5955.8%
  • 60-7459%
  • 75+65.1%

A quarter of people under 30 tested this broadly already have two conditions. From 45 on it is more than half.

Commonest combinations

people with exactly this set of conditions, tested in 3+ areas

  • Dyslipidaemia + Anaemia647
  • Hypothyroid + Anaemia563
  • Anaemia + Transaminitis558
  • Diabetes + Anaemia546
  • Fatty liver + Anaemia542
  • Diabetes + Dyslipidaemia483
  • CKD/albuminuria + Anaemia304
  • Dyslipidaemia + Transaminitis252
  • Dyslipidaemia + Fatty liver251
  • Fatty liver + Transaminitis243

What one condition says about another

adults tested for both; odds ratio adjusted for age and sex

If a person hasthey also havevs withoutaOR
CKD (eGFR<60)82.7% Anaemia57.1%2.8 (2.4–3.3)
Diabetes77.8% Fatty liver54.4%2.3 (2.0–2.6)
Hyperuricaemia20.9% CKD (eGFR<60)9.3%2.9 (2.3–3.7)
CKD (eGFR<60)26.1% Structural heart dis.8.5%2.3 (1.6–3.3)
Diabetes23.9% Proteinuria (dipstick)8.7%2.3 (1.9–2.9)
Diabetes17.2% CKD (eGFR<60)8.1%1.8 (1.6–2.0)
Fatty liver23.9% LVH15.5%1.5 (1.2–1.9)
High TG60.9% Low HDL37.6%2.6 (2.4–2.9)

Kidney disease is the hub: it links to anaemia, the heart, uric acid and diabetes.

Cardiovascular-kidney-metabolic stage

adapted from AHA 2023 staging to what lab results can show; adults with a metabolic or kidney test, n = 52,671

  • Stage 0: no risk factors found43.2%
  • Stage 1: prediabetes or fatty liver32.6%
  • Stage 2: diabetes, triglycerides 135+ or kidney disease20.5%
  • Stage 3: advanced kidney disease or early heart change on echo2.9%
  • Stage 4: heart disease on echo or ECG0.7%

Stage 2 or above: 4.8% at 18-29, 32.7% at 45-59, 44.3% at 75 and over. Blood pressure and weight are not in lab records, so stages 1 and 2 are undercounted.

Checks that never happen

Guidelines ask for an HbA1c, a kidney check (creatinine and urine ACR) and a lipid profile at least once a year in diabetes, and a urine ACR in anyone with low eGFR. These are the shares who ever had each test at this lab in four years.

diabetes n = 7,843eGFR < 60 n = 1,975fatty liver n = 15,434

People with diabetes: ever tested

one diabetic-range result or more, n = 7,843

  • Creatinine47.8%
  • HbA1c36.6%
  • Lipid profile31.7%
  • Liver ultrasound19%
  • Echocardiogram9.2%
  • Urine ACR7.2%

Where the missing tests were done they found a lot: eGFR under 60 in 17.2%, albuminuria in 53.2% and fatty liver in 77.8%. Fewer than one in thirteen people with diabetes ever had the urine test that catches kidney damage early.

Latest HbA1c in people with diabetes

among those who had one

  • Under 7%37%
  • 7 to 7.9%26.1%
  • 8 to 8.9%14.8%
  • 9 to 9.9%8.1%
  • 10% or more14%

36.9% are at 8% or above, and 49.6% of those who started there were still there at their latest test.

Kidney disease

eGFR under 60 at any test, n = 1,975

  • Ever had a urine ACR13.5%
  • Anaemic, with eGFR under 6082.7%
  • Anaemic, with eGFR 60 or more57.1%

Stages: G1 25, G2 81, G3a 860, G3b 483, G4 308, G5 218. 526 people reached G4 or G5, the range where a nephrologist should already be involved.

Fatty liver

fatty liver on ultrasound, n = 15,434

  • Ever had liver enzymes (LFT)16.1%
  • Raised enzymes, where tested42.5%
  • FIB-4 not low, where computable37.9%

Grades: 11,978 grade I, 2,422 grade II, 87 grade III. FIB-4 is the blood score that decides who needs a fibrosis scan; it needs ALT, AST and platelets, which most scanned people never had.

What changes in the same person

27,448 adults came more than once and 9,371 were followed for a year or more. Their first and latest results show how fast conditions start and worsen when nobody is following them up.

25.7%
of people with prediabetic fasting sugar reached the diabetic range
19 per 100 person-years; n 1,000; 24% returned to normal
-2.3
mL/min per year, median eGFR change
n 1,277; 35.6% lost 5 or more a year
26.8%
of normal livers were fatty at the next scan
n 775, scans 6 months or more apart
6.0
new eGFR under 60 per 100 person-years with diabetes
vs 3.7 without; 47 and 26 events

New conditions during follow-up

negative in the first 180 days, retested later, followed a year or more

  • Diabetes25.7% 294 of 1,142
  • CKD (eGFR<60)8.9% 58 of 652
  • Hypothyroid25.8% 127 of 492
  • High LDL10.1% 37 of 366
  • Anaemia39.9% 143 of 358
  • High TG22.4% 57 of 254
  • Transaminitis24.4% 54 of 221
  • Hyperuricaemia30.5% 57 of 187

One in four people whose sugar or thyroid was normal at first had crossed over by a later test. People who come back are not a random sample: many return because something felt wrong, so these rates are high for the population. Subclinical hypothyroidism mostly settled: 56% normalised and 3.2% became overt (n 570).

The follow-up tool, on demo patients

Real names and phone numbers cannot go on a public page, so this section runs the follow-up tool on a simulated cohort shaped like the lab's records. It shows how condition lists merge into one call per person; none of its counts are findings.

11,403 simulated peopleas of 23 Sep 2026

Calls this week

keep-in-care queues, all five conditions, simulated

  • One list per condition1,801
  • One call per person1,397

22.4% fewer calls for the same overdue checks. Each call books one home collection, and every overdue test runs from the same blood draw; only the urine ACR needs a second container.

If someone is on this list, how often are they on that one

% on the row's pathway also on the column's, simulated

also on
DiabetesKidney diseaseCholesterolThyroidFatty liver
Diabetes
100%
14%
45%
7%
28%
Kidney disease
42%
100%
45%
7%
25%
Cholesterol
61%
20%
100%
8%
24%
Thyroid
22%
8%
18%
100%
16%
Fatty liver
42%
12%
26%
7%
100%
rows: on this pathway
ConditionOn pathwayDue this weekLost nowFollow-up tests
Diabetes2,01866348.9%HbA1c, fasting glucose
Kidney disease66123040.5%creatinine, urine ACR
Cholesterol1,47742348.7%lipid profile
Thyroid63016550.2%TSH
Fatty liver1,37632038.4%LFT, CBC

Diabetes has its own page, /diabetes. Each tab below holds a condition's simulated cohort, who gets lost, its call list and the guideline rules behind it.

Kidney disease follow-up, from creatinine the lab already runs

Creatinine is one of the most-ordered tests at Anubhav Life Care, Barasat, but the report shows a number in mg/dL, not kidney function. This tab turns every creatinine into an eGFR, confirms chronic kidney disease the way KDIGO asks (a raised marker lasting more than three months), sets the recall interval from the KDIGO heat map, and ranks who to call when the next check is missed.

661
people on the follow-up pathway
of 6,185 tested
40.5%
of them lost to follow-up now
268 people, 180+ days past due
147
overdue, still reachable
0 to 180 days past due
40
critical + high this week
the top of the call list

Where the cohort stands today

Everyone with at least one of the relevant tests (8,329bills), using each person's latest results. Linking turned the 12,343 PATIENT_KEYs across all their visits into 6,185 people.

Who was tested

sex as recorded; age at latest visit

6,185
people
52 : 48
female : male
569
18–29
1,062
30–39
1,648
40–49
1,482
50–59
844
60–69
580
70+

Latest eGFR

5,836 people

G1 ≥ 90: 3,409 (58.4%)G2 60–89: 1,823 (31.2%)G3a 45–59: 278 (4.8%)G3b 30–44: 206 (3.5%)G4 15–29: 100 (1.7%)G5 < 15: 20 (0.3%)5,836PEOPLE
  • G1 ≥ 903,40958%
  • G2 60–891,82331%
  • G3a 45–592785%
  • G3b 30–442064%
  • G4 15–291002%
  • G5 < 15200%

On the pathway, by sex and age

% of people tested with egfr under 60 or urine acr 30+

age
18–2930–3940–4950–5960–6970+
Female
2%
4%
7%
11%
18%
28%
Male
2%
4%
10%
12%
15%
24%

A referral lab, not a survey: people are tested because a doctor suspected something. The age gradient is the useful part.

Where people on the pathway sit now

n = 661; 42.1% also have a diabetic-range result

  • Raised once, not yet confirmed48.1% 318
  • CKD, very high risk21% 139
  • CKD, high risk17.4% 115
  • CKD, moderate risk12.9% 85
  • CKD, low risk0.6% 4

KDIGO grid for everyone on the pathway

latest eGFR stage × latest urine ACR, n = 641; colour is KDIGO risk, small number is checks per year

eGFR stageA1 < 30A2 30–300A3 > 300ACR never done
G1 ≥ 900 1×9 1×0 2×0
G2 60–893 1×18 1×6 2×1
G3a 45–5952 1×48 2×5 3×173
G3b 30–4447 2×49 3×5 3×105
G4 15–2931 3×26 3×4 4×39
G5 < 159 4×4 4×1 4×6

324 of 641 people (51%) have never had a urine ACR, so their real KDIGO risk is unknown. Albuminuria is the earlier and cheaper warning; this column is the first thing to fix.

People with diabetes: the yearly kidney pair

n = 2,018 with a diabetic-range result

  • Ever had a creatinine (eGFR)69.7%
  • Ever had a urine ACR25.7%

ADA and KDIGO ask for both every year. The blood test is routine; the urine test that catches diabetic kidney disease earliest is the one that gets skipped.

Found only by urine

people on the pathway with a normal eGFR but ACR 30+

51
people
7.7%
of the pathway

Without urine ACR these people would not be on any list: their creatinine looks fine.

Following the same people over time

The clock starts at each person's first result that put them on the pathway. Someone is lost to follow-up once they are more than 180 days past their due date with no follow-up test here.

The follow-up cascade

people who joined the pathway at least 12 months ago, n = 441; each step counts people who also passed every step above

  • eGFR under 60 or urine ACR 30+100% 441
  • Came back for any follow-up test67.1% 296
  • Repeat within 4 months (confirms CKD)15% 66
  • Still testing in the last 12 months8.8% 39
  • Both eGFR and urine ACR in the last year4.8% 21
Show as table
StepPeople% of start
eGFR under 60 or urine ACR 30+441100%
Came back for any follow-up test29667.1%
Repeat within 4 months (confirms CKD)6615%
Still testing in the last 12 months398.8%
Both eGFR and urine ACR in the last year214.8%

Still in care, months after the first abnormal result

Kaplan-Meier, censored at 23 Sep 2026

0%25%50%75%100%0 mo6 mo12 mo18 mo24 mo30 moNo own numberOwn mobile
  • Own mobile on file (n = 524)
  • Agent's number or none (n = 137)

At 12 months 54% of people with their own number are still in care, against 13% without one (only 10 still at risk in that group by then, so the line stops early).

Gap between consecutive eGFR tests

748 repeat tests in people on the pathway

25%
≤ 3 mo
39%
3–6 mo
17%
6–9 mo
9%
9–12 mo
6%
12–18 mo
5%
> 18 mo
  • Within 6 months
  • Longer

36% of repeat tests arrive more than 6 months after the previous one, even among people who do come back.

Month-end status of everyone on the pathway so far

last 24 months

  • On track or due soon
  • Overdue, still reachable (0 to 180 days)
  • Lost (over 180 days past due)

The lost pool grows from 61 to 268. The overdue-but-reachable band averages 141 over the last six months: that middle band is where a call list pays off.

Show as table
Month endOn trackOverdueLost
31 Oct 20241168261
30 Nov 20241178073
31 Dec 20241249076
31 Jan 20251369180
28 Feb 20251379695
31 Mar 20251449999
30 Apr 2025145107107
31 May 2025150113116
30 Jun 2025151116127
31 Jul 2025163120135
31 Aug 2025169110151
30 Sep 2025168118156
31 Oct 2025184125159
30 Nov 2025189123174
31 Dec 2025198117187
31 Jan 2026194131196
28 Feb 2026202130201
31 Mar 2026221129207
30 Apr 2026229128215
31 May 2026227141226
30 Jun 2026232148230
31 Jul 2026239132251
31 Aug 2026213152265
23 Sep 2026246147268

Who gets lost

Share of people lost within 12 months of joining the pathway, among those who joined at least a year ago. Overall: 53.5%. People without their own mobile on file are lost at 89% and 85%, against 46% for people with one.

Contact on file

% lost within 12 months

  • Own mobile46% n = 359
  • Agent's number only89% n = 55
  • No usable number85% n = 27

First came through

% lost within 12 months

  • Walk-in, Barasat51% n = 223
  • Home collection52% n = 103
  • Partner centre62% n = 58
  • Screening camp58% n = 57

Age

% lost within 12 months

  • Under 4063% n = 35
  • 40 to 5954% n = 215
  • 60 and over52% n = 191

Also has diabetes

% lost within 12 months

  • Diabetic-range result on file46% n = 197
  • No diabetic-range result59% n = 244

This week's eGFR call list

People who can still be kept are ranked by how sick and how late they are; people already lost go to a slower re-engagement queue. 230 to keep in care, 268 to re-engage; the top 120 and 40 are loaded here. Open a name to see the timeline.

Keep-in-care queue by who acts
178Care coordinator
24Collection agent
15Duty doctor
13Referring doctor / outreach

120 match · top 120 of 230 in this queue loaded · 0 actioned · 0 booked

  • Critical80
    P-05827 · F · 65y99xxx xx254
    33 mL/min↓9.0eGFR · 7 Jan 2026
    Overdue 137 dayslast test 7 Jan 2026
    Nephrology referral rangeeGFR falling fast+1
    Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
  • Critical79
    P-06984 · M · 42y85xxx xx616
    19 mL/min↓12eGFR · 18 Dec 2025
    Overdue 157 dayslast test 18 Dec 2025
    Nephrology referral rangeeGFR falling fast+2
    Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
  • Critical77
    P-05492 · M · 58y82xxx xx949
    25 mL/min↓16eGFR · 23 Jan 2026
    Overdue 121 dayslast test 23 Jan 2026
    Nephrology referral rangeeGFR falling fast+2
    Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
  • Critical72
    P-02278 · F · 79y90xxx xx126
    33 mL/min↓5.0eGFR · 17 Sep 2025
    Overdue 160 dayslast test 15 Dec 2025
    eGFR falling fastKidney check overdue
    Doctor call first. Book creatinine + urine ACRDuty doctor
  • Critical70
    P-06796 · F · 40y98xxx xx669
    11 mL/min↓12eGFR · 20 Mar 2026
    Overdue 96 dayslast test 20 Mar 2026
    Nephrology referral rangeeGFR falling fast+1
    Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
  • High69
    P-03454 · F · 55y97xxx xx825
    24 mL/mineGFR · 9 Dec 2025
    Overdue 166 dayslast test 9 Dec 2025
    Nephrology referral rangeUrine ACR never done+1
    Book creatinine + urine ACR, refer to nephrologyCare coordinator
  • High69
    P-04732 · M · 45y83xxx xx089
    25 mL/mineGFR · 9 Jan 2026
    Overdue 135 dayslast test 9 Jan 2026
    Nephrology referral rangeUrine ACR never done+1
    Book creatinine + urine ACR, refer to nephrologyCare coordinator
  • High67
    P-01014 · M · 49y78xxx xx665
    44 mL/mineGFR · 1 Dec 2025
    Overdue 174 dayslast test 1 Dec 2025
    eGFR falling fastKidney check overdue
    Book creatinine + urine ACRCare coordinator
  • High66
    P-07749 · F · 61y99xxx xx046
    25 mL/min↓10eGFR · 3 Feb 2026
    Overdue 110 dayslast test 3 Feb 2026
    Nephrology referral rangeUrine ACR never done+1
    Book creatinine + urine ACR, refer to nephrologyCare coordinator
  • High66
    P-04914 · M · 80y92xxx xx331
    37 mL/min↓6.0eGFR · 27 Feb 2026
    Overdue 86 dayslast test 27 Feb 2026
    eGFR falling fastKidney check overdue
    Book creatinine + urine ACRCare coordinator
  • High65
    P-03070 · M · 56y81xxx xx601
    28 mL/mineGFR · 2 Dec 2025
    Overdue 173 dayslast test 2 Dec 2025
    Nephrology referral rangeKidney check overdue
    Book creatinine + urine ACR, refer to nephrologyCare coordinator
  • High65
    P-07143 · M · 47y94xxx xx166
    27 mL/mineGFR · 2 Jan 2026
    Overdue 142 dayslast test 2 Jan 2026
    Nephrology referral rangeKidney check overdue
    Book creatinine + urine ACR, refer to nephrologyCare coordinator
  • High65
    P-07117 · M · 89y78xxx xx158
    20 mL/mineGFR · 15 Feb 2026
    Overdue 98 dayslast test 15 Feb 2026
    Nephrology referral rangeKidney check overdue
    Book creatinine + urine ACR, refer to nephrologyCare coordinator
  • Critical65
    P-01343 · M · 65y87xxx xx594
    5.0 mL/min↓3.0eGFR · 5 Sep 2026
    Due in 73 dayslast test 5 Sep 2026
    Very low eGFR or sudden dropNephrology referral range+1
    Doctor callback within 48 h, repeat creatinine + electrolytesDuty doctor
  • Critical64
    P-02223 · F · 49y75xxx xx279
    8.0 mL/min↓9.0eGFR · 7 Jul 2026
    Due in 13 dayslast test 7 Jul 2026
    Very low eGFR or sudden dropNephrology referral range+1
    Doctor callback within 48 h, repeat creatinine + electrolytesDuty doctor

The rules behind the list

What is due, and when

TriggerNext stepBasis
First eGFR under 60 or urine ACR 30+repeat at 90 daysKDIGO: CKD needs more than 3 months of abnormality
Confirmed CKD, KDIGO low or moderate riskevery 365 daysKDIGO heat map: once a year
KDIGO high risk (e.g. G3a A2, G3b A1)every 183 daysKDIGO heat map: twice a year
KDIGO very high risk (G3b A2+, G4)every 122 daysKDIGO heat map: three times a year
G4 A3 or G5every 91 daysKDIGO heat map: four or more times a year
eGFR under 30 or ACR over 300nephrology referralKDIGO referral criteria
eGFR falling 5+ mL/min a yearflagged on the listKDIGO: rapid progression
No kidney test > 180 days past duemarked lost to follow-upSame rule as the diabetes list

How the priority score is built

0 to 100

FactorPoints
KDIGO risk low / moderate / high / very high8 / 14 / 24 / 32
Raised once, not yet confirmed20
In nephrology referral range+8
eGFR falling 5+ a year+10
Urine ACR never done+4
eGFR under 15, or down 30% within 90 days+10, forces Critical
Days past due (peaks at 180, then decays)up to 25
Due within the next 30 days4
Age 65+5

Critical 70+ (or a result that forces it), High 55 to 69, Medium 38 to 54, Routine below 38.

Definitions and blind spots

eGFR from serum creatinine with the race-free CKD-EPI 2021 equation, using sex and age on the bill; when no sex is recorded (56people) no eGFR is computed rather than guessed. A kidney marker is eGFR under 60 or urine ACR 30 mg/g or more. CKD is confirmed when markers are at least 90 days apart; a single raised marker is “not yet confirmed” and recalled at 3 months. Staging uses the latest eGFR (G1 to G5) and latest ACR (A1 to A3); when ACR was never done the person is staged as A1, which understates risk.

Blood pressure, ACE inhibitor or SGLT2 inhibitor use and dialysis status are not in lab data, and acute illness can lower eGFR for a while.

How the numbers were made

Real, from the lab:every figure from the top of the page through “What changes in the same person”. A read-only script on the clinic PC pulled structured results, bills and imaging report headers from AKTIV after clinic hours (1,74,520 visits, Oct 2022 to Oct 2026). Visits were linked into people by phone number, name, sex and age with the resolver from the diabetes page. Ultrasound and echo reports were turned into yes/no findings by rule-based extractors that ran on the same PC. Names, phone numbers and report text never left it; this page reads only counts and percentages from etl-ncd/analysis/results.

Real, published: every West Bengal and India figure, each linked to its source.

Simulated: the follow-up tool section and its condition tabs. They run the same rules on a generated cohort, because a working call list needs names and phone numbers.

Limits. These are people a doctor sent for testing, not a sample of West Bengal, so rates run above survey rates wherever testing is selective. Someone with one test here may test elsewhere. The ultrasound findings come from keyword rules that have not yet been checked against a hand-read sample. Linking by name and phone can merge two people or split one. Blood pressure, weight and prescriptions are not in lab records.